POSTOPERATIVE RADIOACTIVE IODINE EVALUATION OF TOTAL THYROIDECTOMY FOR THYROID-CARCINOMA - REAPPRAISAL AND THERAPEUTIC IMPLICATIONS

被引:11
作者
ATTIE, JN
BOCK, G
MOSKOWITZ, GW
MARGOULEFF, D
DUBNER, S
机构
[1] LONG ISL JEWISH MED CTR,ALBERT EINSTEIN COLL MED,DEPT SURG,NEW HYDE PK,NY 11042
[2] LONG ISL JEWISH MED CTR,ALBERT EINSTEIN COLL MED,DEPT NUCL MED,NEW HYDE PK,NY 11042
[3] CORNELL UNIV,N SHORE UNIV HOSP,COLL MED,DEPT SURG,MANHASSET,NY 11030
[4] CORNELL UNIV,N SHORE UNIV HOSP,COLL MED,DEPT NUCL MED,MANHASSET,NY 11030
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 1992年 / 14卷 / 04期
关键词
D O I
10.1002/hed.2880140408
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 [耳鼻咽喉科学];
摘要
The records of 430 patients who underwent total thyroidectomy with radioactive iodine (RAI) uptake studies performed postoperatively were reviewed. Indications for the administration of an ablative dose of iodine 131 are given. The majority (85.4%) had no or low (less than 2%) evidence of focal uptake and therefore were not treated with ablative doses of iodine 131. RAI scanning is necessary postoperatively to determine the completeness of the surgical procedure and to detect residual or metastatic disease. Small foci of residual disease or occult distant metastases can be adequately treated with therapeutic doses of RAI. Nodal or distant metastases that become clinically evident following thyroidectomy are usually not successfully treated with RAI.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 21 条
[1]
PRESERVATION OF PARATHYROID-GLANDS DURING TOTAL THYROIDECTOMY - IMPROVED TECHNIQUE UTILIZING MICROSURGERY [J].
ATTIE, JN ;
KHAFIF, RA .
AMERICAN JOURNAL OF SURGERY, 1975, 130 (04) :399-404
[2]
FEASIBILITY OF TOTAL THYROIDECTOMY IN THE TREATMENT OF THYROID-CARCINOMA - POST-OPERATIVE RADIOACTIVE IODINE EVALUATION OF 140 CASES [J].
ATTIE, JN ;
MOSKOWITZ, GW ;
MARGOULEFF, D ;
LEVY, LM .
AMERICAN JOURNAL OF SURGERY, 1979, 138 (04) :555-560
[3]
TREATMENT OF THYROID-CARCINOMA WITH RADIOACTIVE IODINE [J].
BEIERWALTES, WH .
SEMINARS IN NUCLEAR MEDICINE, 1978, 8 (01) :79-94
[4]
BEIERWALTES WH, 1983, THYROID TODAY, V6, P1
[5]
CHANGING CLINICAL, PATHOLOGIC, THERAPEUTIC, AND SURVIVAL PATTERNS IN DIFFERENTIATED THYROID-CARCINOMA [J].
CADY, B ;
SEDGWICK, CE ;
MEISSNER, WA ;
BOOKWALTER, JR ;
ROMAGOSA, V ;
WERBER, J .
ANNALS OF SURGERY, 1976, 184 (05) :541-553
[6]
CADY B, 1988, SURGERY, V104, P947
[7]
THYROID-CANCER - THE CASE FOR TOTAL THYROIDECTOMY [J].
CLARK, OH ;
LEVIN, K ;
ZENG, QH ;
GREENSPAN, FS ;
SIPERSTEIN, A .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02) :305-313
[8]
TOTAL THYROIDECTOMY - THE TREATMENT OF CHOICE FOR PATIENTS WITH DIFFERENTIATED THYROID-CANCER [J].
CLARK, OH .
ANNALS OF SURGERY, 1982, 196 (03) :361-370
[9]
NATURAL-HISTORY, TREATMENT, AND COURSE OF PAPILLARY THYROID-CARCINOMA [J].
DEGROOT, LJ ;
KAPLAN, EL ;
MCCORMICK, M ;
STRAUS, FH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (02) :414-424
[10]
GEORGE FW, 1973, HOSP PRACT, V8, P143